Robert Zeiger MD, PhD

Robert S. Zeiger, MD, Ph.D., Secretary of the Board of Directors. Dr. Zeiger has been a Senior Physician Investigator and Director of Allergy Research for Kaiser Permanente Southern California (KPSC), San Diego, California, Clinical Professor of Pediatrics at the University of California San Diego (UCSD) School of Medicine in La Jolla, California, and Deputy Editor for the Journal of Allergy Clinical Immunology: In Practice. He is Board Certified in Pediatrics and Allergy. Dr. Robert Zeiger was Principal Investigator (PI) for the UCSD/KPSC Clinical Center for the multicenter National Health Lung Blood Institute (NHLB)I sponsored Childhood Asthma Management Program (CAMP) and Childhood Asthma Research and Education (CARE) Network. He is presently PI for the KPSC Clinical Center for the NHLBI-funded Vitamin D Antenatal Asthma Reduction Trial (VDAART). He has recently explored the power of administrative data obtained from large computerized electronic pharmacy and healthcare databases to perform outcome studies on severe asthma, the clinical and cost burden of asthma and chronic obstructive pulmonary disease (COPD), chronic cough, and to conduct innovative clinical trials. “Given the disastrous and troubling opioid epidemic, the high prevalence of unrelenting chronic pain, and the lack of highly effective and safe treatments for chronic pain, there is a major public health need for novel effective medications. More definitive research needs to better understand the current use of cannabis for pain in the United States and to provide future evidence through rigorous clinical trials on the role of cannabis in the treatment of chronic pain, inflammatory conditions, and other chronic conditions.”